Literature DB >> 20094735

Perioperative management for a patient with chronic pancytopenia: a case of aplastic anemia with persistent neutropenia following preoperative administration of G-CSF.

Yoshiko Nakano1, Ryu Okutani.   

Abstract

The patient, a 62-year-old male suffering from aplastic anemia for 6 years, was admitted in order to undergo laparoscopic cholecystectomy for cholecystitis. Results of laboratory tests at the time of admission revealed pancytopenia: white blood cell count, 1.94 x 10(3)/microl (neutrophil count, 1.23 x 10(3)/microl); red blood cell count, 2.09 x 10(6)/microl; Hb 7.5 g/dl; and platelet count, 3.7 x 10(4)/microl. The patient received supportive therapy prior to surgery, including blood transfusion of red blood cells, platelets and granulocyte colony-stimulating factor (G-CSF). On the day of surgery, the white blood cell count increased to 3.93 x 10(3)/microl (neutrophil count, 2.75 x 10(3)/microl). Surgery ended with no intraoperative complications, but neutropenia progressed and persisted postoperatively: the neutrophil count decreased to 180/microl at its lowest and stayed at about 400-600/microl. This suggests the possibility that repeated preoperative administration of G-CSF may lead to the depletion of granulocyte precursor cells and thus cause harm. Although the patient fortunately achieved a favorable outcome without severe infection, this case is a stark reminder of the difficulties involved in perioperative supportive therapy for patients with chronic pancytopenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20094735     DOI: 10.1007/s00540-009-0823-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  8 in total

1.  Guidelines for the use of platelet transfusions.

Authors: 
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

2.  Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.

Authors:  Orin Buetens; R Sue Shirey; Mary Goble-Lee; Julie Houp; Andrea Zachary; Karen E King; Paul M Ness
Journal:  Transfusion       Date:  2006-05       Impact factor: 3.157

Review 3.  Signals for activation of the GM-CSF promoter and enhancer in T cells.

Authors:  M F Shannon; L S Coles; M A Vadas; P N Cockerill
Journal:  Crit Rev Immunol       Date:  1997       Impact factor: 2.214

Review 4.  [Diagnosis and transfusion algorithm for the management of perioperative coagulopathy].

Authors:  Toshiharu Azma; Kyoko Yamasaki; Masashi Mimasu; Masakazu Nakao; Hirosato Kikuchi
Journal:  Masui       Date:  2008-09

5.  Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

Authors:  L C Hartmann; L K Tschetter; T M Habermann; L P Ebbert; P S Johnson; J A Mailliard; R Levitt; V J Suman; T E Witzig; H S Wieand; L L Miller; C G Moertel
Journal:  N Engl J Med       Date:  1997-06-19       Impact factor: 91.245

6.  Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo.

Authors:  E M Sloand; S Kim; J P Maciejewski; F Van Rhee; A Chaudhuri; J Barrett; N S Young
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

Review 7.  Aplastic anaemia.

Authors:  N S Young
Journal:  Lancet       Date:  1995-07-22       Impact factor: 79.321

Review 8.  Risks, benefits, alternatives and indications of allogenic blood transfusions.

Authors:  C Madjdpour; V Heindl; D R Spahn
Journal:  Minerva Anestesiol       Date:  2006-05       Impact factor: 3.051

  8 in total
  1 in total

1.  Anesthetic Management of a Patient With Fanconi Anemia.

Authors:  Saki Nagano; Masanori Tsukamoto; Takeshi Yokoyama
Journal:  Anesth Prog       Date:  2019
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.